BB Biotech AG : Update post T2 2023, OC ajusté à 57 €
>BB Biotech a tenu une présentation aux analystes hier - Le management de BB Biotech a tenu hier une réunion Analystes pour revenir sur les dernières évolutions de son activité à l’issue de la publication de ses résultats T2 2023. Nous en retenons principalement 1/ le maintien de la ligne stratégique d’investissement, 2/ une meilleure dynamique M&A qu’en 2022 et une priorité au deals de type partenariats et 3/ un newsflow clinique et réglementaire qui continuer à aid...Co.'s principal activity is to invest in biotechnology companies globally. The investments are held through its wholly-owned subsidiaries: Biotech Focus N.V., Biotech Invest N.V., Biotech Target N.V., and Biotech Growth N.V., all of which are located in Curacao. Co. acquires holdings in companies in the biotechnology growth market. The focus of the holdings is on quoted companies that are concentrating on the development and marketing of innovative medicines. For the selection of holdings, Co. relies on fundamental analysis by physicians and molecular biologists.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.